NRAS and myelodysplastic syndrome: By contrast, a comprehensive molecular analysis of 77 pediatric MDS and MDS/MPN patient samples revealed Mo7/del(7q) in 40% and PTPN11, NRAS, and other Ras pathway mutations in 55% [12].